| FABIA: factor analysis for bicluster acquisition S Hochreiter, U Bodenhofer, M Heusel, A Mayr, A Mitterecker, A Kasim, ... Bioinformatics 26 (12), 1520-1527, 2010 | 387 | 2010 |
| JNJ-26481585, a novel second-generation oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity J Arts, P King, A Marin, W Floren, A Belin, L Janssen, I Pilatte, B Roux, ... Clinical Cancer Research 15 (22), 6841-6851, 2009 | 240 | 2009 |
| The cost of melanization: Butterfly wing coloration underenvironmental stress W Talloen, HV Dyck, L Lens Evolution 58 (2), 360-366, 2004 | 198 | 2004 |
| Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome J Aerssens, M Camilleri, W Talloen, L Thielemans, HWH Göhlmann, ... Clinical Gastroenterology and Hepatology 6 (2), 194-205, 2008 | 168 | 2008 |
| I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data W Talloen, DA Clevert, S Hochreiter, D Amaratunga, L Bijnens, S Kass, ... Bioinformatics 23 (21), 2897-2902, 2007 | 154 | 2007 |
| Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection MF Yuen, EJ Gane, DJ Kim, F Weilert, HLY Chan, J Lalezari, SG Hwang, ... Gastroenterology 156 (5), 1392-1403. e7, 2019 | 139 | 2019 |
| Quantitation of pretreatment serum interferon‐γ–inducible protein‐10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment … JM Darling, J Aerssens, G Fanning, JG McHutchison, DB Goldstein, ... Hepatology 53 (1), 14-22, 2011 | 134 | 2011 |
| Functional conservation units for the endangered Alcon Blue butterfly Maculinea alcon in Belgium (Lepidoptera: Lycaenidae) D Maes, W Vanreusel, W Talloen, H Van Dyck Biological Conservation 120 (2), 229-241, 2004 | 131 | 2004 |
| Gene expression studies using Affymetrix microarrays H Gohlmann, W Talloen Chapman and Hall/CRC, 2009 | 111 | 2009 |
| Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project B Verbist, G Klambauer, L Vervoort, W Talloen, Z Shkedy, O Thas, ... Drug discovery today 20 (5), 505-513, 2015 | 107 | 2015 |
| Does the presence of ant nests matter for oviposition to a specialized myrmecophilous Maculinea butterfly? H Dyck, JGB Oostermeijer, W Talloen, V Feenstra, A Hidde, I Wynhoff Proceedings of the Royal Society of London. Series B: Biological Sciences …, 2000 | 107 | 2000 |
| JNJ-56136379, an HBV capsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection F Zoulim, O Lenz, JJ Vandenbossche, W Talloen, T Verbinnen, I Moscalu, ... Gastroenterology 159 (2), 521-533. e9, 2020 | 101 | 2020 |
| Microcontaminant accumulation, physiological condition and bilateral asymmetry in zebra mussels (Dreissena polymorpha) from clean and contaminated surface waters J Voets, W Talloen, T de Tender, S Van Dongen, A Covaci, R Blust, ... Aquatic Toxicology 79 (3), 213-225, 2006 | 74 | 2006 |
| Genome‐wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays M Tuefferd, A De Bondt, I Van Den Wyngaert, W Talloen, T Verbeke, ... Genes, Chromosomes and Cancer 47 (11), 957-964, 2008 | 73 | 2008 |
| VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering BMP Verbist, K Thys, J Reumers, Y Wetzels, K Van der Borght, W Talloen, ... Bioinformatics 31 (1), 94-101, 2015 | 70 | 2015 |
| EEG alpha power as an intermediate measure between brain-derived neurotrophic factor Val66Met and depression severity in patients with major depressive disorder HFA Zoon, CPM Veth, M Arns, W Drinkenburg, W Talloen, PJ Peeters, ... Journal of Clinical Neurophysiology 30 (3), 261-267, 2013 | 59 | 2013 |
| Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout M Versele, W Talloen, C Rockx, T Geerts, B Janssen, T Lavrijssen, P King, ... Molecular cancer therapeutics 8 (7), 1846-1855, 2009 | 58 | 2009 |
| Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled … K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ... The Lancet Infectious Diseases 22 (12), 1703-1715, 2022 | 51 | 2022 |
| Applied biclustering methods for big and high dimensional data using R Z Shkedy, S Kaiser, S Hochreiter, W Talloen CRC Press Taylor & Francis Group, 2016 | 46 | 2016 |
| Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis AC Ravindranath, N Perualila-Tan, A Kasim, G Drakakis, S Liggi, ... Molecular BioSystems 11 (1), 86-96, 2015 | 39 | 2015 |
Hinrich WH GöhlmannScientific Director at Johnson & Johnson在 its.jnj.com 的电子邮件经过验证
